Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.

Sarah Verhoeff; Pim P. van de Donk; Erik H. J. G. Aarntzen; Iris Harriette Cornelia Miedema; Sjoukje Oosting; Jens Voortman; Adrienne H. Brouwers; Marije Slingerland; Sandra Heskamp; Carla M. L. Van Herpen

Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.

Sarah Verhoeff, Pim P. van de Donk, Erik H. J. G. Aarntzen, Iris Harriette Cornelia Miedema, Sjoukje Oosting, Jens Voortman, Adrienne H. Brouwers, Marije Slingerland, Sandra Heskamp, Carla M. L. Van Herpen

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Journal of clinical oncology
Volume	38
Issue number	15
Publication status	Published - 20 May 2020

Cite this

@article{e0c65aa0b68544b293d5dd252944b1ee,

title = "Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.",

author = "Sarah Verhoeff and {van de Donk}, {Pim P.} and Aarntzen, {Erik H. J. G.} and Miedema, {Iris Harriette Cornelia} and Sjoukje Oosting and Jens Voortman and Brouwers, {Adrienne H.} and Marije Slingerland and Sandra Heskamp and {Van Herpen}, {Carla M. L.}",

year = "2020",

month = may,

day = "20",

language = "English",

volume = "38",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

}

TY - JOUR

T1 - Zr-89-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.

AU - Verhoeff, Sarah

AU - van de Donk, Pim P.

AU - Aarntzen, Erik H. J. G.

AU - Miedema, Iris Harriette Cornelia

AU - Oosting, Sjoukje

AU - Voortman, Jens

AU - Brouwers, Adrienne H.

AU - Slingerland, Marije

AU - Heskamp, Sandra

AU - Van Herpen, Carla M. L.

PY - 2020/5/20

Y1 - 2020/5/20

M3 - Meeting Abstract

SN - 0732-183X

VL - 38

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 15

ER -